Why Nektar Therapeutics Stock Rocked it Today [Globe and Mail, The (Toronto, Canada)]
Nektar Therapeutics (NKTR)
Last nektar therapeutics earnings: 2/27 04:15 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.nektar.com/investor-relations
Company Research
Source: Globe and Mail, The
The company plans to advance the drug through its pipeline. A restorative hair treatment helped restore the value of Nektar Therapeutics (NASDAQ: NKTR) on Monday. The company reported very promising results from a clinical trial of a drug targeting a hair-loss disorder, generating significant heat for its stock. The biotech 's shares thundered more than 18% higher that day as a result. Growing optimism Before market open, Nektar -- still a clinical-stage company -- published results from a phase 2b study of its rezpegaldesleukin in patients with severe to very severe alopecia areata. The trial found that patients who had already responded to the treatment grew more hair over time. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » Image source: Getty Images. With that, optimism returned in a big way to rez
Show less
Read more
Impact Snapshot
Event Time:
NKTR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NKTR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NKTR alerts
High impacting Nektar Therapeutics news events
Weekly update
A roundup of the hottest topics
NKTR
News
- Why Nektar Therapeutics Stock Rocked it Today [Yahoo! Finance]Yahoo! Finance
- Nektar Therapeutics: 'Strong Buy' On REZPEG POC Established In AD/AA And Late-Stage Development [Seeking Alpha]Seeking Alpha
- Nektar Therapeutics Announces Proposed Public Offering [TheStreet.com]TheStreet.com
- Nektar Therapeutics Announces Proposed Public OfferingPR Newswire
- NKTR Investor Alert: Nektar Therapeutics Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Misleading Institutional Shareholders: Levi & KorsinskyGlobeNewswire
NKTR
Earnings
- 3/12/26 - Beat
NKTR
Sec Filings
- 4/20/26 - Form 424B5
- 4/20/26 - Form 8-K
- 4/20/26 - Form 8-K
- NKTR's page on the SEC website